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Abstract The purpose of this study was to evaluate
the impact of computed tomography coronary angiog-
raphy (CTCA) on the appropriate utilization of catheter
angiography (CA). This observational trial analyzed
all patients undergoing CA in 2006 and 2007 in one
hospital. In 2007, patients having a low to intermediate
cardiovascular risk and suspicion of coronary artery
disease (CAD) and those with suspicion of progression
of known organic heart disease (OHD) underwent
CTCA either prior to CA or as the sole imaging
modality. Appropriate utilization of CA was defined
as: (1) percentage of patients showing normal or
non-significant findings at CA, (2) percentage of self-
referred patients to CA, and (3) percentage of patients
with known OHD undergoing CA without immediate
operative or interventional consequences. Use of
CTCA resulted in a significant drop in the percentage
of CA examinations in patients with suspected CAD
showing normal or non-significant findings (19% in
2006, 10% in 2007, P \ 0.001). The percentage of
self-referred CA significantly dropped (29% in 2006,
10% in 2007, P \ 0.001). CT ruled-out CAD in 74/151
(49%) patients, obviating subsequent CA. During a
follow-up of 15 ± 4 months, CA and percutaneous
interventions was considered necessary in 2/74
patients. CT ruled-out progression of known OHD in
53/60 (90%) patients, while one patient underwent CA
and percutaneous intervention during a follow-up
period of 16 ± 4 months. No reduction of CA exam-
inations without immediate consequences was found in
patients with known OHD (13% in 2006, 27% in 2007).
In patients with suspicion of CAD, CTCA improved
the appropriate utilization of CA without jeopardizing
patient safety, along with a decrease of self-referred
patients for CA. CTCA did not influence the appropri-
ate utilization of CA in patients with known OHD.
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Introduction
The frequency of non-obstructive coronary artery
disease (CAD) or negative findings at coronary cath-
eter angiography (CA) has been proposed to be a
surrogate marker for assessing the appropriate utiliza-
tion of the invasive procedure [1–6]. The implicit
assumption of this concept is that a high rate of non-
significant disease or normal findings at CA might
indicate an inappropriate use, which could reflect poor
clinical judgment, inaccurate non-invasive studies, or
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possible self-interest [1]. Because the evaluation of the
appropriate utilization of medical procedures is impor-
tant to monitor the quality of care, to contain costs, and
to enhance the safety by reducing inappropriate
invasive procedures [7, 8], quality control (QC) criteria
pertaining to the indication of CA have been defined
[9]. Despite of these criteria, however, the incidence of
normal or non-significant CA examinations has been
reported to be around 30% [10, 11], which has brought
into question the appropriate utilization of the invasive
procedure [1–6].
Multi-slice spiral computed tomography (CT) has
recently emerged as a non-invasive tool for the
anatomical imaging of the coronary arteries. The
accuracy of CT coronary angiography (CTCA) for
diagnosis or exclusion of CAD has been amply
documented in various studies directly comparing
CTCA with CA [12–15]. On the other hand, as with
any new technologic innovation there is potential for
misunderstanding and abuse. Despite the definition of
appropriate utilization criteria for CTCA [16], con-
cerns exist that the current boom of 64-slice and dual-
source CT scanners and examinations could lead to
unnecessary additional costs through an increase in
the rate of CA in case of intermediate, non-diagnos-
tic, or false positive CTCA examinations [17, 18].
Thus, over or misuse of cardiac CT could in turn have
a negative effect on the appropriate utilization of CA.
In this study, we assessed the impact of clinically
integrated CTCA with regard to the appropriate
utilization of CA in patients with suspected CAD and
in patients with known organic heart disease (OHD).
Methods
The study setting is a cardiology practice involving
ambulatory non-invasive as well as invasive diagnosis,
treatment, and consultancy in a private for-profit
hospital, and the radiology institute of a public, non-
profit University Hospital. All consecutive patients
undergoing CA and/or percutaneous interventions (PCI)
during January 1st and December 31st in the years 2006
and 2007 were included in this retrospective study.
From the beginning of 2007 on, a modern CT
scanner became available for cardiac imaging. Thus,
during 2007 all patients presenting with chest pain
and having a low or intermediate pre-test probability
of CAD, in whom the electrocardiogram (ECG) was
equivocal or uninterpretable, and/or who were unable
to exercise or delivered a submaximal stress test were
subjected to CTCA, being in line with current
recommendations [16]. In contrast, in the year 2006
all patients with similar symptoms, ECG and stress
test findings directly underwent invasive work-up
with CA.
In both years, all patients with chest pain and
having a high pre-test probability of CAD were
directly subjected to CA.
Patients presenting with or who were suspected of
having an acute coronary syndrome were excluded
from CTCA because the non-invasive modality is
considered inappropriate for this indication [16].
Women below 40 years of age were also excluded
from CTCA to keep radiation doses at a minimum
because some of these patients eventually needed
subsequent CA.
The protocol was approved by the local ethical
committee who waived the informed consent
requirement.
Study population
Patients undergoing CTCA were grouped as follows:
those in which CAD was excluded, those in which a
de-novo diagnosis of CAD was made, and those who
underwent CTCA with previously documented OHD.
Patients undergoing CA were similarly grouped:
those in which CAD was excluded, those in which
CAD was diagnosed de-novo, and those with previ-
ously known OHD. OHD was defined to include
coronary, valvular, or congenital heart disease, car-
diomyopathy, or dysrhythmia requiring treatment
(excluding sinus tachy- or bradycardia).
The appropriate utilization of CA was defined as
previously shown [1–6]:
– The percentage of patients examined by CA with
suspicion of de-novo CAD but showing no
significant stenoses; and
– The proportion of patients without significant
stenoses that were self-referred to CA by the
examining cardiologist;
Appropriate utilization of CA was additionally
extended to include:
– The percentage of patients with known OHD
undergoing CA without immediate therapeutic
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consequences (e.g., percutaneous coronary inter-
vention (PCI), coronary bypass surgery, valve
replacement or repair, or pacemaker implantation).
In the further analysis, these three sub-groups were
considered separately and were not summed-up to a
single group.
CT protocol and data reconstruction
All patients were scanned on a dual-source CT scanner
(Somatom Definition, Siemens Medical Solutions,
Forchheim, Germany). An initial non-enhanced scan
was performed for calcium scoring. Calcium scoring
was performed for the purpose to give recommenda-
tions on the use of statins. Then, all patients received a
single dose of 2.5 mg isosorbiddinitrate s. l. (Isoket,
Schwarz Pharma, Monheim, Germany). No beta-
blockers were given prior to CT in any patient. About
80 mL of iopromidum (Ultravist 370, 370 mg/mL,
Bayer Schering Pharma, Berlin, Germany) was
injected at a flow rate of 5 mL/s followed by 30 mL
saline solution. Contrast agent application was con-
trolled by bolus-tracking in the ascending aorta (signal
attenuation threshold 100 HU).
Scanning parameters were: detector collimation
2 9 32 9 0.6 mm, slice collimation 2 9 64 9 0.6 mm
by means of a z-flying focal spot, and gantry rotation
time 330 ms. In patients with a regular heart rate below
70 beats per minute (bpm), CT was performed with
prospective electrocardiography (ECG)-gating and
using attenuation-based tube current modulation (ref-
erence tube current time product: 190 mAs/rotation).
The data acquisition window was set at 70% of the RR-
interval.
At heart rates above 70 bpm or at irregular heart
rates, CT was performed with retrospective ECG-
gating employing a heart rate-adapted pitch of 0.2–0.5
and a tube current time product of 330 mAs/rotation.
ECG-pulsing for radiation dose reduction was used in
all patients as previously recommended [19]. The tube
potential was set at 120 kV in patients with a body
mass index (BMI) above 25 kg/m2 and at 100 kV in
patients with a BMI below 25 kg/m2. Both non-
enhanced and contrast-enhanced CT scans were per-
formed from the level of the tracheal bifurcation to the
diaphragm in a cranio-caudal direction.
According to the dose-length products of the
individual examinations (306-606 mGy 9 cm and
59-212 mGy 9 cm, respectively) and using a con-
version coefficient of 0.017 (mSv/[mGy 9 cm]), the
effective radiation doses of the retrospectively ECG-
gated protocols were 6.9 ± 2.6 mSv (range 5.2–
10.3 mSv), and those of the prospectively ECG-gated
protocols 2.2 ± 0.6 mSv (range 1.0–3.6 mSv), being
in line with previous reports [20, 21].
Non-enhanced CT scans were reconstructed at
70% of the R–R interval using 3.0 mm non-overlap-
ping slices (reconstruction kernel B35f). Contrast-
enhanced CT scans were reconstructed within the
RR-intervals of full tube current. CT images were
reconstructed with a slice thickness of 0.75 mm, a
reconstruction increment of 0.5 mm, and using a soft-
tissue convolution kernel (B26f). In presence of
vessel wall calcifications, additional images were
reconstructed using a sharp-tissue convolution kernel
(B46) to compensate for blooming artifacts.
CT data analysis
Coronary segments were defined according to a
scheme proposed by the American Heart Association
(AHA) [22]. The right coronary artery (RCA) was
defined to include segments 1–4; the left main artery
(LM) to consist of segment 5, the left anterior
descending artery (LAD) to include segments 6–10,
and the left circumflex artery (LCx) to include
segments 11–15. The intermediate artery was desig-
nated as segment 16, if present, and considered to
belong to the LAD.
All CTCA data analysis was performed during
daily clinical practice by one experienced reader who
was aware of the clinical history of the patients.
Calcifications were quantified with scoring software
(Syngo CaScore, Siemens). All lesions on more than
two contiguous pixels with attenuation values greater
than 130 HU were marked and the calcium load in
each patient was computed by using the Agatston
method [23]. All coronary artery segments were
assessed for the presence of significant stenoses,
defined as luminal diameter narrowing[50%. Vessel
diameters were measured on reconstructions perpen-
dicularly oriented to the vessel centerline.
The report of each cardiac CT examination
included the Agatston score, the age and gender-
matched percentile of the Agatston score [24], the
information about the presence or absence of coro-
nary stenoses, and the %-degree of stenoses, if
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present. The report was written at the day of each CT
examination and was subsequently sent per mail to
the referring cardiologist.
Catheter angiography
CA was performed according to standard techniques
and at least three views in different planes were
obtained for each coronary artery. The first author
who was aware of the patients’ clinical history and to
the results from cardiac CT (which preceded CA in
every patient) performed and evaluated all angio-
grams with regard to the presence (diameter reduction
[50%) or absence of significant coronary stenoses.
Coronary artery segments were defined according to
the same AHA scheme as for CT [22]. All CA and
CT examinations were performed within 4 weeks.
Clinical follow-up
All patients who were primarily excluded from CA
but subjected to CTCA were strongly encouraged to
undergo CA if chest pain persisted, or increased in
duration, intensity, or frequency. This applied also to
patients in whom the character of chest pain changed
(for example if it became exclusively stress- or
exercise-induced), and to those in whom an additional
stress test performed within the follow-up time interval
was positive for ischemia.
Mid-term follow-up information was obtained from
all patients by either clinical visits or telephone
interviews. The cardiologist discussed symptoms, the
occurrence of any major adverse cardiac events
(MACE) including myocardial infarction, heart fail-
ure, evolution of angina pectoris, coronary artery
bypass graft surgery, PCI, or death, as well as hospital
admission or repeated CA procedures.
Statistical analysis
Continuous variables were expressed as means ±
standard deviation (SD) and were compared using a
paired t-test. Significance was assumed at a P value
\0.05. Categorical variables are reported as counts
and percentages. Pearson correlation coefficients were
computed for linear correlation analysis. Sensitivity,
specificity, positive predictive value, and negative
predictive value were calculated from Chi-Square tests
of contingency, using the written reports of each CTCA
examination, with CA as the standard of reference.
Statistics for the diagnostic performance of CTCA
were calculated on a per-vessel (i.e., at least one
significant stenosis or absence of any significant
stenosis in one coronary artery), and on a per-patient
basis (i.e., at least one significant stenosis or absence of
any significant stenosis per patient). All non-evaluative
coronary segments at CTCA were considered as false-
positive findings on an intent-to-diagnose basis,
because every patient with a non-evaluative segment
would undergo CA in clinical practice, as previously
shown [25]. All data were analyzed using commer-
cially available statistical software (StatView 5.0;
ASA Institute Inc., Cary, NC, USA).
Results
Year 2006
In 2006, a total number of 248 patients (81 female,
mean age 67.3 ± 10.3 years, range 18–90 years)
underwent CA and/or PCI (excluding interventions
in two patients for atrial septal defect (ASD) closure)
(Fig. 1).
From these 248 patients, CAD could be excluded in
48 (19.4%) (Table 1), CAD was diagnosed in 73
(29.4%) (Table 2), and 127 patients (51.2%) had
known OHD (Table 3). In the group of patients
showing no significant CAD, 14 (29%) were self-
referred by the examining cardiologist. In the group of
patients with known OHD, the CA examinations
resulted in immediate therapeutic (i.e., interventional
or surgical) consequences in 111 of the 127 patients
(87%). Forty-four of the patients (35%) with known
OHD were self-referred by the examining cardiologist.
Year 2007
In the year 2007, a total of 347 patients were included
in the study (Fig. 1).
CTCA
From these 347 patients, 151 patients (43.5%) were
primarily referred to CTCA. CTCA was successfully
performed in all of these 151 patients, and no
procedure-related side-effects occurred. Fourty-four
of the 151 patients (29%) continued taking their
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baseline beta-receptor antagonist medication at the
time of CT, no additional medication for heart rate
control was administered prior to the scans. The mean
heart rate during CTCA was 67 ± 15 bpm (range
52–102 bpm). At CTCA, diagnostic image quality
was found in 98.7% of all segments (2252/2282),
while image quality of 30 segments (1.3%; RCA,
n = 14; LAD, n = 7; LCx, n = 9) was considered
non-diagnostic and thus were rated as false-positive.
CTCA excluded significant CAD in 74 of the 151
patients (49.0%) (Table 4). CAD as a de-novo
diagnosis was detected in 17 patients (11.3%). In
the 60 patients (35.8%) with known OHD, progres-
sion of known CAD and/or de-novo CAD could be
excluded in 54, while progression and/or de-novo
CAD in those who were known to suffer from non-
coronary cardiac disease was found in six patients
(Table 5).
Catheter angiography
From the 347 patients studied in 2007, 196 (56.5%)
primarily underwent invasive work-up with CA
(Fig. 1). Clinically suspected CAD was excluded by
CA in 20 patients (10.2%) (Table 1), 65 (33.2%)
were diagnosed to have a de-novo CAD (Table 2),
whereas 111 (56.6%) suffered from known OHD
(Table 3).
CA was performed additionally in 23 patients after
obtaining the results from CTCA (including 17
patients with a de-novo diagnosis of CAD and 6
with a progression of known OHD), leading to a total
number of 219 CA examinations in 2007 (being
significantly less than in 2006, P \ 0.0001).
Fig. 1 Patient management
flow chart of the study
Table 1 Characteristics of patients undergoing catheter angi-
ography showing no significant coronary artery disease in the
years 2006 and 2007
2006 2007
Total number (females) 48 (28) 20 (13)
Age in years (range) 63.5 (37–90) 60.9 (40–82)
Referral pattern
EC 14 (29%) 2 (10%)
RC 25 (52%) 13 (65%)
RP 8 (17%) 5 (25%)
H 1 (2%) –
Stress test positive 8 5
Negative 11 6
Borderline 9 5
Not done 20 4
CCS class I: 8 I: 1
II: 29 II: 13
III: 11 III: 6
CA coronary angiography, CCS angina pectoris class according
to Canadian Cardiovascular Society criteria, EC indication for
CA by examining cardiologist, H indication for CA by external
hospital, RC indication for CA by referring cardiologist, RP
indication for CA by referring physician
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Comparison between 2006 and 2007
The number of patients undergoing CA but having no
CAD significantly (P \ 0.0001) decreased in 2007 as
compared to 2006 (20 patients representing 10.2% of
those 196 undergoing CA in 2007 versus 48 patients
representing 19.4% of the 248 undergoing CA in 2006,
Table 1).
Similarly, the number of self-referrals in this patient
group significantly (P \ 0.0001) decreased in 2007 (2
representing 10% versus 14 representing 29% of the
patients undergoing CA in 2007 and 2006, Table 1). In
the same period of time, the proportion of patients
referred to CA by external doctors (including external
hospital, referring cardiologist, and referring physician)
significantly increased (P \ 0.001), because CTCA was
not used as a filter test in these patients (i.e., the patients
were directly referred to invasive work-up).
The percentage of patients with a de-novo diagnosis
of CAD at CA that was followed by an immediate
therapeutic consequence decreased significantly
(P \ 0.05) from 89% in 2006 to 84% in 2007, owing
mainly to a decrease in PCI procedures (Table 2).
In patients with known OHD, the rate of thera-
peutic procedures after invasive diagnosis signifi-
cantly (P \ 0.0001) decreased from 87% in 2006 to
73% in 2007 (Table 3). During the same period of
time, the proportion of patients with known OHD
who were self-referred to CA by the author remained
unchanged (35 vs. 36%, P = n.s.).
Comparison between CTCA and CA
Twenty-three patients underwent CA after a de-novo
diagnosis of CAD or a progression of known CAD at
CTCA (Fig. 2). In these patients, the sensitivity,
specificity, positive and negative predictive value of
CTCA was 100% each in the per-patient based
analysis, with lower values in the per-vessel based
analysis (Table 6). The correlation regarding the
percent stenosis estimation between CTCA and CA
Table 2 Characteristics of patients undergoing catheter angi-
ography showing significant coronary artery disease as a de-novo
diagnosis
2006 2007
Total number (female) 73 (14) 65a (30)
Age in years (range) 67.4 ± 10.1
(39–88)
68.0 ± 10.4
(37–87)
Referral pattern
EC 16 (22%) 40 (46%)
RC 29 (40%) 22 (25%)
RP 22 (30%) 20 (23%)
H 6 (8%) 5 (6%)
Treatment
PCI 45 (62%) 48 (55%)
ACB 20 (27%) 25 (29%)
Conservative 8 (11%) 12 (14%)
Other (PTA, AVA/
PM)
– 2 (2%)
ACB Aorto-coronary bypass surgery, EC indication for CA by
examining cardiologist, H indication for CA by external
hospital, PCI Percutaneous coronary intervention, PTA
peripheral angioplasty, RC indication for CA by referring
cardiologist, RP indication for CA by referring physician, AVA/
PM AV node ablation and pacemaker implantation. Only the
main intervention is indicated, some patients underwent more
than one procedure (e.g., PCI and PTA)
a The 23 patients with a de-novo diagnosis of CAD and those
with a progression of known OHD made with CT in 2007 are
excluded
Table 3 Characteristics of patients undergoing catheter angi-
ography with known organic heart disease
2006 2007
Total number (female) 127 (39) 111 (32)
Age in years (range) 66.4 ± 10.6
(32–89)
67.6 ± 12.0
(26–92)
Referral pattern
EC 44 (35%) 40 (36%)
RC 47 (37%) 39 (35%)
RP 20 (16%) 29 (26%)
H 16 (13%) 4 (4%)
Treatment
PCI 50 (39%) 37 (33%)
ACB* 11 (9%) 8 (7%)
Conservative 16 (13%) 30 (27%)
Other (AVA/PM, PTA,
VS)**
36 (28%) 18 (16%)
PFO/ASD-C 9 (8%) 19 (17%)
ACB Aortocoronary bypass, AVA/PM AV node ablation and
pacemaker insertion, CA coronary angiography, EC examining
cardiologist, H Hospital, PCI percutaneous coronary intervention,
PTA percutaneous angioplasty of peripheral or renal artery, RC
referring cardiologist, RP referring physician, VS valvular surgery
* Some patients underwent combined ACB and VS
** Including aortic aneurysm surgery
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was significant (P \ 0.001), with highest correlation
coefficients for the RCA (r = 0.92), followed by the
LAD (r = 0.84) and the LCx (r = 0.77).
Clinical follow-up
From the 74 patients in whom significant stenoses
were ruled-out at CTCA, 72/74 had no MACE in the
mid-term follow-up period of 15.2 ± 3.7 months
(range 12–24 months). Two of the patients with
normal CTCA had recurrent angina necessitating
CA that revealed a significant stenosis of the LCx and
an in-stent restenosis of the LAD, respectively.
Table 4 Characteristics of patients in whom significant
coronary artery disease was excluded with CT
N = 74
Age in years (range) 62 ± 11 (37–87)
Gender 41 females
CVRF Positive family history: 42
(57%)
Hyperlipidemia 43 (58%)
Smoking 28 (38%)
Hypertension 35 (47%)
Diabetes mellitus 3 (4%)
Symptoms* Chest pain 53 (72%)
Dyspnea 7 (9)
None 16 (22)
Syncope 1 (1.4%)
PE 1 (1.4%)
CVI 1 (1.4%)
Stress test Negative 32 (43%)
SM 29 (39%)
Borderline 6 (8%)
Positive 4 (5%)
None 1 (1%)
BBB 2 (3%)
Agatston score according
to age and gender-matched
percentile [24]
Between 0–25%: 32
Between 25–50%: 9
Between 50–75%: 10
Between 75–90%: 15
Above 90%: 8
% stenosis at CT (range) LAD 7% ± 15 (0–50%)
LCx 4% ± 12 (0–50%)
RCA 4% ± 11 (0–50%)
MACE 2; 2.7% (CA and PCI)
Follow-up time in months
(range)
15.2 ± 3.7 (12–24)
BBB bundle branch block, CVI cerebrovascular insult, CVRF
cardiovascular risk factors, LAD left anterior descending artery,
PE pulmonary edema during competition sport, RCA right
coronary artery, LCx left circumflex artery, SM clearly
submaximal work load at stress test due to deconditioning or
invalidating knee, hip or back pain (mostly preoperative
screening), MACE major adverse cardiac events
* More than one symptom or none possible
Table 5 Characteristics of patients with known organic heart
disease undergoing CT
N = 60a
Age in years (range) 70 ± 9.7 (40–87)
Gender 17 Females
CVRF Positive family history 39 (72%)
Hyperlipidemia 44 (81%)
Smoking 18 (33%)
Hypertension 38 (70%)
Diabetes mellitus 6 (11%)
CAD or organic heart
disease known prior
to CT
CAD post bypass 9 (17%)
CAD post-PCI 25 (46%)
CAD* 8 (15%)
Valvular heart disease 3 (6%)
ASD 2 (4%)
Cardiomyopathy 2 (4%)
Atrial fibrillation 3 (6%)
Cor pulmonale 1 (2%)
Coronary anomaly (left main from
right coronary) 1 (2%)
Stress test None 13 (24%)
Negative 23 (43%)
Submaximal 8 (15%)
Positive 6 (11%)
Borderline 4 (7%)
MACE 1; 1.7% (CA and PCI)
Follow-up time in months
(range)
16.1 ± 4.2 (12–24)
Interventions ASD closure in 2 patients
MACE major adverse cardiac events, CAD coronary artery
disease, ASD atrial septal defect
* Patients with a history of myocardial infarction or maximally
a 60% stenosis and no PCI
a Progression of CAD or de-novo CAD in patients with known
non-coronary cardiac disease was ruled-out with CT in 54
patients in whom no subsequent catheter angiography was
performed. Six patients showed progression of disease and
underwent subsequent catheter angiography
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Retrospective analysis of CTCA in these two patients
confirmed the initial report with a patent stent and no
significant coronary stenoses (Figs. 3 and 4). None of
the other 72 patients were referred to CA within the
follow-up time interval.
From the 54 patients with known OHD undergoing
CT to rule-out progression of known CAD and/or de-
novo CAD in those with known non-coronary cardiac
disease, one patient suffered from recurrent angina
necessitating CA. In this patient, CA revealed an
occluded stent in the LAD. Retrospective analysis of
CTCA in this patient confirmed the initial report of a
patent stent. No MACE occurred and no therapeutic
cardiac (i.e., coronary) procedures were deemed
necessary in the other 53 patients during the mean
follow-up period of 16.1 ± 4.2 months (range 12–24
months). Two patients from this group underwent
ASD closure within this time interval.
All patients having an intermediate risk of cardio-
vascular disease and Agatston scores above the 75th
age- and gender-matched percentile [24] as well as
having non-obstructive CAD were selected for more
aggressive target values for lipid-lowering therapy
(i.e., statins) and were advised to take salicylic acid
medication, as previously recommended [26].
Discussion
This observational study has been intended to inves-
tigate the role of cardiac CT on the appropriate
utilization of CA. By virtue of its design, the study
has four major strengths. First, it represents—to
the best of our knowledge—the first investigation
exploring the usefulness, efficiency, and safety of the
incorporation of non-invasive coronary angiography
Fig. 2 A 66-year-old male patient with a de-novo diagnosis of
CAD at dual-source CTCA. A normal right coronary (a) and
left circumflex (b) artery is depicted, but a significant stenosis
of the mid-left anterior descending artery (c and d) caused by a
soft plaque is shown (arrows). The stenoses was subsequently
confirmed at catheter angiography (e, arrow), with subsequent
successful angioplasty and stenting (not shown)
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with CT into daily clinical practice. Second, the study
excludes any bias due to conflicts of interest. The two
persons and institutions involved played a comple-
mentary role in this study although in general being
competitors (i.e., one working in a public non-profit,
the other in a private for-profit institution). Third, it
would be in the very financial interest of one of the
authors (the referring cardiologist) to perform as
many coronary angiographies as possible, whereas
the other author (the interpreting radiologist) is being
salaried with no financial incentive to increase the
numbers of CT examinations. Fourth, we have
explicitly applied our measures of appropriate utili-
zation to a small unit of observation at the level of
two centers and physicians, as previously suggested
[6, 27].
In this study, we used the known QC criteria
percentage of patients undergoing CA but having no
or non-significant CAD and the percentage of self-
referred patients for testing the appropriate utilization
of CA [1–6]. We extended these QC criteria by
considering also the percentage of patients with
known OHD undergoing CA without interventional
or surgical consequences.
By doing so, our study shows that the integration
of CTCA into the clinical patient management helps
to rationalize the use of CA in patients referred with a
clinical suspicion of CAD. In this group, substantially
less patients showing normal or non-significant CAD
underwent CA, and less of these patients were self-
referred by the examining cardiologist. This could be
achieved through the use of CTCA as a filter test
while subjecting those patients to the non-invasive
modality who had chest pain and a low to interme-
diate cardiovascular risk profile, an equivocal or
uninterpretable ECG, and/or who were unable to
exercise in a sufficient manner. Interestingly, this
group of patients exactly represents that population
that has been recommended by various international
societies to benefit most from non-invasive coronary
angiography with CT [16, 26, 28].
The incidence of morbidity and mortality associ-
ated with CA is low, however, not negligible.
Table 6 Per-vessel and per-patient based analysis of the
diagnostic performance of dual-source CT compared to CA for
the identification of significant ([50%) coronary stenosis in the
23 patients who underwent both modalities
Number of patients = 23 LAD LCx RCA Patients*
Stenoses correctly
identified (%)
13/14 5/7 7/9 20/20*
Stenoses missed (%) 1/14 2/7 2/9 0/20*
Stenoses incorrectly
diagnosed (%)
0 1 0 0/20*
Sensitivity (%) 93 71 78 100
Specificity (%) 100 94 100 100
Positive predictive value (%) 100 83 100 100
Negative predictive value (%) 90 88 88 100
LAD left anterior descending, RCA right coronary artery, LCx
left circumflex artery
* 20/23 patients had significant stenosis of at least one main
vessel (LAD, LCx, RCA). Three patients had significant
stenosis of a diagonal branch, two of which were correctly
identified by CT, one was missed, the patient had persistent
typical symptoms and thus underwent CA. Two stenoses at
posterolateral branches of the LCx were missed at CT
Fig. 3 A 59-year-old male patient. Curved multi-planar
reformations of the left anterior descending artery showing
patent stents in the proximal and mid-segment (a). CA
performed 8 months later due to recurrent chest pain revealed
a high-grade in-stent restenosis in the proximal segment
(arrow, b)
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According to several studies, CA implies risks to the
patient through a major complication rate of up to
1.7% [29]. Thus, the use of CA should be performed
in accordance with current guidelines, such as those
of the American College of Cardiology and American
Heart Association [9]. Nevertheless—and notwith-
standing the use of these guidelines—normal or
non-significant CA examinations in such a population
remain [30] and expose the patients to the risk of a
potentially inappropriate invasive procedure. Our
study demonstrates that CTCA can be used as a safe
filter test either as an alternative to CA in patients
showing no CAD, or as an anatomical imaging
modality rationalizing the use of invasive work-up
with CA.
During the follow-up period up of this study, two
of 74 patients in the group examined by CTCA for
de-novo CAD and one of 54 patients from the group
with known OHD underwent CA and PCI. These
three patients suffered from recurrent angina more
than 8 months after CTCA, and none of these patients
suffered from myocardial infarction, cerebrovascular
event, heart failure or death. Retrospective analysis of
the CTCA examinations in these three patients
confirmed the initial report. Thus, progression of
CAD may have played a role in these patients.
Many unnecessary CA examinations are performed
in patients having some OHD of no prognostic
significance (e.g., patients with atypical symptoms
and no ischemia that had undergone a PCI or ACB
surgery in the past, or patients with mild to moderate
valvular heart disease in which stress testing is
equivocal). Use of CTCA as a filter test in these
patients did not decrease the number of inappropriate
CA examinations (defined as invasive work-up without
therapeutic consequences). In contrast, the percentage
of patients not undergoing any intervention after CA
increased. The cause of this finding either reflects a
chance effect when dealing with a numerically small
population or may reflect a selection bias, i.e., a lower
threshold of indication for CA in patients with known
OHD. This must be weighed against the benefit for
patients with known OHD who were investigated only
by CTCA that safely documented the absence of
progression of known CAD and/or de-novo CAD in
those with known non-coronary cardiac disease.
In Switzerland, CA is more expensive than cardiac
CT by a factor of 5- to 12-fold (the latter in persons
with a private health insurance). Thus, the costs for
the 74 patients where CTCA ruled-out CAD added to
the costs of the 54 patients where progression of CAD
and/or de-novo CAD in patients with OHD was
ruled-out with CTCA must be weighed against the
costs in the 23 patients who underwent both invasive
and non-invasive work-up.
The effective radiation doses of our CTCA proto-
cols ranged between 1 and 10 mSV, depending on the
Fig. 4 A 65-year-old male patient. Curved multi-planar
reformations of the left circumflex artery shows vessel wall
irregularities but no significant stenosis (a). CA performed
6 months later shows a high-grade stenoses (arrow) in the
proximal segment (b)
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protocol used. These values must be opposed to those
of diagnostic CA examinations that have been
reported to range between 2 and 23 mSv [31].
Similar to the financial aspects mentioned above,
the cumulative radiation doses in the 23 patients
undergoing both anatomic imaging modalities must
be weighted against the 128 patients who only
underwent CTCA.
In the 23 patients undergoing both CTCA and CA,
the correlation regarding the degree of stenoses was
good, with similar results as in previous studies [13,
32]. The overall diagnostic performance for the
identification of patients having significant stenoses
was excellent and corroborates with previous studies
comparing the accuracy of CTCA with CA [12–15].
It must be noted, however, that the subgroup of
patients available for this comparison is biased
through the inclusion of only those patients showing
significant stenoses at CTCA and by the knowledge
of the CT findings by the examining cardiologist
performing CA.
Study limitations
The study reports only the practice of a single center
low-volume cardiology practice (248, respectively,
219 invasive diagnostic procedures in 2006 and 2007,
and 95, respectively, 85 PCI procedures, in addition to
other interventions). On the other hand, this may
reflect the practice of a substantial number of cardi-
ologists working in non-academic settings, both in the
U.S. and in Europe and has been suggested to be
the optimal size for such observations [6, 27]. Second,
the term ‘‘significance’’ when using small numbers
must be interpreted with caution. Third, the follow-up
period in our study was only approximately one and a
half years, and no long-term risk prediction in our
patients undergoing CT is available. Finally, we did
not use the most modern CT scanner technology and
protocols [33–35] which may have further lowered the
radiation exposure to our patients.
Conclusions
In patients with chest pain having a low- to interme-
diate risk for CAD and an equivocal or uninterpret-
able ECG, and/or who are unable to exercise in a
sufficient manner, CTCA can be used as a test that
helps to rationalize the use of CA without putting a
risk on the mid-term outcome of the patients.
Implementing cardiac CT into clinical routine results
in an improved appropriate utilization of CA exam-
inations through a reduction of purely diagnostic
invasive work-up and at the same time reduces the
rate of self-referred patients. In patients with known
OHD, in contrast, the use of cardiac CT proved not to
enhance the appropriate utilization of CA procedures
because the rate of invasive work-up without thera-
peutic consequences was not reduced.
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